SMTL ID : 7lq7.1

Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.40 Å

Oligo State

hetero-3-3-3-3-3-mer

Ligands

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 4 residues within 4Å: Chain A: F.6, G.7, N.11, V.35 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:V.35 Hydrogen bonds: A:N.11 NAG.2: 2 residues within 4Å: Chain B: G.7, N.11 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:N.11 NAG.3: 2 residues within 4Å: Chain E: G.7, N.11 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cho, H. et al., Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern. Sci Transl Med (2021)

Release Date

2021-09-15

Peptides

Spike protein S1: ABE
CV503 heavy chain: CFM
CV503 light chain: DGH
COVA1-16 heavy chain: IKL
COVA1-16 light chain: JNO

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

E
E

C
C

F
F

M
H

D
D

G
G

H
L

I
T

K
P

L
y

J
U

N
Q

O
z

Spike protein S1

CV503 heavy chain

CV503 light chain

COVA1-16 heavy chain

COVA1-16 light chain

Related Entries With Identical Sequence